D
Revolution Medicines, Inc. RVMD
$39.12 $0.090.23%
Recommendation
Sell
Prev Close
$39.12
Volume
810,430
Avg Vol (90D)
1,532,378
Market Cap
$7.27B
Dividend & Yield
--
52-Week Range
$29.55 - $62.40
P/E (TTM)
--
EPS (TTM)
-$3.57
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Very Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
Revolution Medicines (RVMD, $39.12) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 14, 2025
3/15/2025 - Tickeron - Technical Analysis
Revolution Medicines (RVMD, $38.89) Stochastic Oscillator left the oversold zone on March 11, 2025
3/12/2025 - Tickeron - Stocks
Victory Capital Management Inc. Trims Holdings in Revolution Medicines, Inc. (NASDAQ:RVMD)
3/12/2025 - MarketBeat
Revolution Medicines (RVMD, $36.82) Stochastic Oscillator left the oversold zone on March 10, 2025
3/11/2025 - Tickeron - Stocks
Revolution Medicines (RVMD, $36.82) Stochastic Oscillator left the oversold zone on March 10, 2025
3/11/2025 - Tickeron - Stocks
Charles Schwab Investment Management Inc. Buys 167,997 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)
3/11/2025 - MarketBeat
Bank of New York Mellon Corp Has $24.89 Million Stock Holdings in Revolution Medicines, Inc. (NASDAQ:RVMD)
3/10/2025 - MarketBeat
Proficio Capital Partners LLC Purchases New Holdings in Revolution Medicines, Inc. (NASDAQ:RVMD)
3/9/2025 - MarketBeat
Revolution Medicines (RVMD, $39.21) Stochastic Oscillator left the oversold zone on March 07, 2025
3/8/2025 - Tickeron - Stocks
Revolution Medicines, Inc. (NASDAQ:RVMD) is Alphabet Inc.'s 4th Largest Position
3/8/2025 - MarketBeat
E Fund Management Co. Ltd. Raises Stake in Revolution Medicines, Inc. (NASDAQ:RVMD)
3/7/2025 - MarketBeat
Revolution Medicines, Inc. (NASDAQ:RVMD) Shares Bought by Candriam S.C.A.
3/7/2025 - MarketBeat
Revolution Medicines Moves Up In Market Cap Rank, Passing Invesco
3/6/2025 - The Online Investor
Revolution Medicines (RVMD, $38.34) price may climb as it broke lower Bollinger Band on Mar 03, 2025
3/4/2025 - Tickeron - Stocks
Revolution Medicines, Inc. (RVMD): Among the Cash-Rich Mid Cap Stocks to Buy Now
3/3/2025 - Insider Monkey
10 Cash-Rich Mid Cap Stocks To Buy Now
3/3/2025 - Insider Monkey
Revolution Medicines (NASDAQ:RVMD) Price Target Raised to $73.00
3/3/2025 - MarketBeat
Revolution Medicines price target raised to $73 from $72 at H.C. Wainwright
3/3/2025 - TipRanks Financial Blog
Revolution Medicines price target raised by $1 at H.C. Wainwright, here's why
3/3/2025 - The Fly
Wedbush Lifts Earnings Estimates for Revolution Medicines
3/3/2025 - MarketBeat
Revolution Medicines (NASDAQ:RVMD) Given "Outperform" Rating at Wedbush
2/28/2025 - MarketBeat
Stifel Nicolaus Issues Pessimistic Forecast for Revolution Medicines (NASDAQ:RVMD) Stock Price
2/28/2025 - MarketBeat
Needham & Company LLC Has Lowered Expectations for Revolution Medicines (NASDAQ:RVMD) Stock Price
2/28/2025 - MarketBeat
Revolution Medicines (RVMD, $39.08) price may climb as it broke lower Bollinger Band on Feb 27, 2025
2/28/2025 - Tickeron - Stocks
Revolution Medicines (RVMD, $39.08) Stochastic Oscillator left the oversold zone on February 27, 2025
2/28/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$683.00M
EBIT (TTM)
-$689.52M
Net Income (TTM)
-$600.09M
Balance Sheet
Total Assets (Q)
$2.56B
Total Debt (Q)
$135.84M
Total Liabilities (Q)
$293.10M
Book Value Per Share (Q)
$12.19
Cash Flow
Cash from Operations (TTM)
-$557.44M
Cash from Investing (TTM)
-$554.39M
Cash from Financing (TTM)
$959.41M
Net Change in Cash (TTM)
-$152.42M
Filings
Filing Date
Wednesday, February 26, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.35
7-Day Total Return
-0.25%
30-Day Total Return
-8.92%
60-Day Total Return
-12.50%
90-Day Total Return
-28.99%
Year to Date Total Return
-11.09%
1-Year Total Return
22.90%
2-Year Total Return
70.23%
3-Year Total Return
113.77%
5-Year Total Return
95.60%
52-week Low
Apr 05, 2024 - $29.55
52-week High
Nov 11, 2024 - $62.40
Valuation
Market Cap
$7.27B - Mid Cap
Enterprise Value
$5.12B
Price/Sales (TTM)
--
Price/Book (Q)
3.21
Dividends and Shares
Shares Outstanding
173.76M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.revmed.com
Phone Number
650 481 6801
Address
700 Saginaw Drive
Redwood City, CA 94063
Country
United States
Year Founded
2014
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company’s research and development pipeline includes... more
NASDAQ 03/14/2025 4:00PM Eastern Quotes delayed
Weiss Ratings